ImmunityBio IBRX
NASDAQ IBRX
$9.44 +0.61 (+6.91%)
As of: Sep 30, 2026 · 3:59 PM EDT

ImmunityBio (IBRX) Equity Income (2021 - 2023)

Updated

ImmunityBio's Equity Income came in at -$7.55 million for FY2023, compared with -$12.11 million in FY2022.

Analysis

ImmunityBio (IBRX) Equity Income (2021 - 2023) Analysis & Trends

  • Per Business Quant, earlier years put Equity Income at -$12.11 million in FY2022 and -$803,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -10.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 ImmunityBio 9.30 Bn 8.06 Bn 50.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -1.26 Mn
Jun 30, 2023 -3.96 Mn
Mar 31, 2023 -2.34 Mn
Dec 31, 2022 -3.55 Mn
Sep 30, 2022 -4.46 Mn
Jun 30, 2022 -3.90 Mn
Mar 31, 2022 -197,000.00
Dec 31, 2021 -803,000.00
API Access

ImmunityBio Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=IBRX&period=max&api_key=YOUR_API_KEY